3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans.
about
Toxicity of amphetamines: an updateMethylenedioxymethamphetamine ('Ecstasy')-induced immunosuppression: a cause for concern?The pharmacology and toxicology of "ecstasy" (MDMA) and related drugsRaves: a review of the culture, the drugs and the prevention of harm.Neonatal amphetamine exposure and hippocampus-mediated behaviors."Partying" hard: party style, motives for and effects of MDMA use at rave parties.Differential experiences of the psychobiological sequelae of ecstasy use: quantitative and qualitative data from an internet study.The Health Effect of Psychostimulants: A Literature ReviewAn exploration of the history and controversies surrounding MDMA and MDA.Mechanisms mediating the ability of caffeine to influence MDMA ('Ecstasy')-induced hyperthermia in ratsThe role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivativesInstability of the ecstasy market and a new kid on the block: mephedrone.Human psychobiology of MDMA or 'Ecstasy': an overview of 25 years of empirical research.Acute toxic effects of club drugs.Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research.Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk.Investigating the potential neurotoxicity of Ecstasy (MDMA): an imaging approach.Neurotoxicity of drugs of abuse--the case of methylenedioxyamphetamines (MDMA, ecstasy), and amphetamines.Acute psychological and neurophysiological effects of MDMA in humans.MDMA misrepresentation: an unresolved problem for Ecstasy users.Hydrolysis of 3,4-methylenedioxymethamphetamine (MDMA) metabolite conjugates in human, squirrel monkey, and rat plasma.Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): a stressor on the immune system.MDMA (3,4-Methylenedioxymethamphetamine) or ecstasy: the neuropsychobiological implications of taking it at dances and raves.Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy.Effects of MDMA, MDA and MDEA on blood pressure, heart rate, locomotor activity and body temperature in the rat involve alpha-adrenoceptorsMDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.Metabolic syndrome in drug abuse.Understanding recreational ecstasy use in the United States: a qualitative inquiry.Simultaneous liquid chromatographic-electrospray ionization mass spectrometric quantification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) and its metabolites 3,4-dihydroxymethamphetamine, 4-hydroxy-3-methoxymethamphetamine and 3,4-methyleneValidated liquid chromatographic-electrospray ionization mass spectrometric assay for simultaneous determination of 3,4-methylenedioxymethamphetamine and its metabolites 3,4-methylenedioxyamphetamine, 3,4-dihydroxymethamphetamine, and 4-hydroxy-3-meEffects of MDMA, methamphetamine and methylphenidate on repeated acquisition and performance in rats.Drug metabolism in the horse: a review.Changes in leptin, ghrelin, growth hormone and neuropeptide-Y after an acute model of MDMA and methamphetamine exposure in rats.Serotonin transporter expression is not sufficient to confer cytotoxicity to 3,4-methylenedioxymethamphetamine (MDMA) in vitro.Diabetic ketoacidosis complicated by the use of ecstasy: a case report.Tumour necrosis factor alpha suppression by MDMA is mediated by peripheral heteromeric nicotinic receptors.Gas chromatography/mass spectrometry analysis of the six-ring regioisomeric dimethoxybenzyl-N-methylpiperazines (DMBMPs).Neuroendocrine and subjective responses to pharmacological challenge with citalopram: a controlled study in male and female ecstasy/MDMA users.Methylenendioxyamphetamine produces serotonin nerve terminal loss and diminished behavioural and neurochemical responses to the antidepressant fluoxetine.A one-generation reproductive toxicity study of 3,4-methylenedioxy-n-methamphetamine (MDMA, Ecstasy), an amphetamine derivative, in C57BL/6 mice.
P2860
Q22252794-612BF46A-F518-4FB8-810A-6E21BD63E801Q24627529-2861DCCC-0C51-4C4B-A90F-550E5F69E097Q28361466-537002A4-FCE0-4A28-9FE6-047F6E4C4255Q30327023-16DFCDB0-C870-4A63-8FA2-7DD7BF754EBAQ30483016-E6938D28-5B01-4657-93E8-704EAC06E938Q30541451-6AB70839-4496-4F2B-B918-93FA83658E73Q31005994-B26AA90C-3A97-4D40-8EDE-258BA66E2521Q33677986-D9F77E63-318D-4971-BD2C-E71A62C9E11FQ34102744-3CE7BCE3-5107-4456-AEE6-EE0218C9FF37Q34112855-C5AE6BA7-A6B6-4963-B1DD-3550B47F5A0EQ34112933-79D77109-327A-4425-8EC5-78B2160B85EAQ34136889-160AFB9F-5D07-4995-937F-1D654FCD0F27Q34359604-09415A77-EE16-4250-8A24-6AD8C8545B77Q34370377-1E57807E-0FEC-40A5-B8FA-C0E9C858F126Q34528465-81C266A6-C10B-4E98-9EF5-F44C34F1F486Q34647657-AB997F2F-1932-4854-A26E-39549F57207DQ34982523-72F83826-78A2-43CE-86C4-B31BF1EC0AD2Q35010538-7115FA03-6143-4164-B8C3-36B191E93E18Q35105559-0541199D-9F36-4BF0-A007-6DF2AB43B690Q35105565-81470B8B-D5C9-403E-BD23-C4EC7A4103A5Q35184723-FA1DD5DA-7163-4FB0-9C54-25124254EC38Q35729190-CC53111E-FD9F-4053-96CC-D938036AB35CQ35946697-3111F47B-C01F-4810-B933-538522630629Q36020276-23615FC4-FE70-435C-AD19-C555C17483F2Q36357993-EBE73E32-E75C-455E-9FCA-C6F0256772A6Q36410784-8C7AE9DE-036C-4F99-9EE6-9506E92627E0Q37031208-F540E788-D295-4ED4-9A36-D818257A629EQ37071416-2406C25C-9FE9-4F08-A39A-CF7FDE4ACCE1Q37161392-2A269063-79C0-430E-8C00-48DF7F6118EAQ37193466-6AD0E377-1DFC-40E7-B6BC-C6F4262D8E72Q37392237-EA15273B-25B3-4F71-998A-F872E8C60938Q37802313-17B8DF21-DA5F-4E2D-8AB1-AB1D3AB166D7Q40168155-C4999938-6AD4-49E4-A8F8-E29CB6D37E49Q40309889-0D2A9DBF-390A-49CE-AD18-B979E767CC44Q41995404-E8929222-DA90-4179-AB0E-C55277B22F09Q43182900-E0567A24-D6E2-4836-BC1F-AE610038A93CQ43873058-D0D238D5-85CA-4FEB-8659-BC73C0D7FC3EQ44255973-A7D764CC-120C-4CB2-B823-2C0F8F547515Q44553347-80CF1D22-6C0C-4BF3-AEBF-E2F27A16ED64Q45307662-46C8A9D0-F4F0-452A-8A76-B3951825B436
P2860
3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans.
@ast
3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans.
@en
3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans.
@nl
type
label
3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans.
@ast
3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans.
@en
3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans.
@nl
prefLabel
3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans.
@ast
3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans.
@en
3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans.
@nl
P1476
3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans
@en
P2093
P304
P356
10.1016/S0149-7634(98)00046-3
P577
1999-03-01T00:00:00Z